Radiation Therapy for Liver Metastases: Clinical Data
Author; year Design Pts with liver metastases Frx × dose m-FU mts Local control 2-years (%) Survival 1-, 2-years (%) Severe morbidity Schefter 2005 [19] Phase I 18 3 × 12–20 Gy NR NR NR…
Radiation Therapy for Hepatocellular Carcinoma: Clinical Data
Authors Patients Tumor diameter/volume (tumor number) Dose/fraction size Objective response rate (%) Overall survival Toxicity ≥G3 (%) Ben-Josef et al. [11] 128 /Liver Malignancies – Median 60.75 Gy /1.5 Gy BID (40–90 Gy)…
Multidisciplinary Model for Liver Tumors
Time Patient 1 Patient 2 Patient 3 Patient 4 Patient 5 Patient 6 7:30–11:30 CT: 07:30 Check-In 08:00 Scan CT: 07:50 Check-In 08:20 Scan Lab: 07:30 Lab: 08:00 Lab: 08:15…
Liver Metastases: Basic Principles of Treatment and Clinical Data
Authors (year published) Number Mortality (%) Morbidity (%) 5-year disease-free survival (%) 5-year overall survival (%) Nordlinger et al. (1996) [14] 1568 2 23 15 28 Fong et al. (1999)…
Sustainability and Spread
Source and domain/setting Definition Characterized as benefits persistence/continuation development Merriam-Webster [20] (English dictionary) • “able to be used without being completely used up or destroyed” • “able to last or…
Quality and Safety in Hematopoietic Stem Cell Transplant Patients
Fig. 17.1 Quality and safety metrics in hematopoietic stem cell transplantation. Adopted from Rice and Bailey [31] Donor Safety As unrelated hematopoietic cell (HC) donation is only reserved for individuals…
Implementation of Evidence-Based Care in Pediatric Hematology/Oncology Practice
Author Year Location TTA before QI process (Min) TTA after QI process (Min) Percent decrease Amado [7] 2011 PICU 164 55 66% Pakakasam [14] 2011 ED 180 75 58% Burry…
Chemotherapy and Medication Safety
Fig. 10.1 Severity index for categorizing medication errors from NCC MERP (Used with permission. © 2001 National Coordinating Council for Medication Error Reporting and Prevention) Classification of Processes Involved in…
Principles of Patient Safety in Pediatric Hem/Onc/HSCT
Disincentives for reporting adverse events Poor education about what constitutes an event Concern over legal or credentialing consequences Personal shame Fear of implicating others Time-consuming processes Systems that are difficult…
Quality in Pediatric Palliative Care
Presence of complex chronic or life-limiting condition Difficult pain or physical symptom management Emotional or social distress Unable to perform activities of daily living resulting in poor quality of life…
